Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma

R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, Cancer Statistics, 2021, CA: a cancer journal for clinicians, 71 (2021) 7-33. Alterio, 2019, Modern radiotherapy for head and neck cancer, Semin Oncol, 46, 233, 10.1053/j.seminoncol.2019.07.002 D. Adelstein, M.L. Gillison, D.G. Pfister, S. Spencer, D. Adkins, D.M. Brizel, B. Burtness, P.M. Busse, J.J. Caudell, A.J. Cmelak, A.D. Colevas, D.W. Eisele, M. Fenton, R.L. Foote, J. Gilbert, R.I. Haddad, W.L. Hicks, Y.J. Hitchcock, A. Jimeno, D. Leizman, W.M. Lydiatt, E. Maghami, L.K. Mell, B.B. Mittal, H.A. Pinto, J.A. Ridge, J. Rocco, C.P. Rodriguez, J.P. Shah, R.S. Weber, M. Witek, F. Worden, S.S. Yom, W. Zhen, J.L. Burns, S.D. Darlow, NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017, Journal of the National Comprehensive Cancer Network : JNCCN, 15 (2017) 761-770. Lawrence, 2013, Mutational heterogeneity in cancer and the search for new cancer-associated genes, Nature, 499, 214, 10.1038/nature12213 Razzouk, 2014, Translational genomics and head and neck cancer: toward precision medicine, Clin Genet, 86, 412, 10.1111/cge.12487 Barker, 2015, The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence, Nat Rev Cancer, 15, 409, 10.1038/nrc3958 Sharabi, 2015, Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy, The Lancet Oncology, 16, e498, 10.1016/S1470-2045(15)00007-8 Scott, 2017, A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study, The Lancet Oncology, 18, 202, 10.1016/S1470-2045(16)30648-9 Eschrich, 2009, A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation, Int J Radiat Oncol Biol Phys, 75, 489, 10.1016/j.ijrobp.2009.06.014 Eschrich, 2009, Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform, Int J Radiat Oncol Biol Phys, 75, 497, 10.1016/j.ijrobp.2009.05.056 Eschrich, 2012, Validation of a radiosensitivity molecular signature in breast cancer, Clinical cancer research : an official journal of the American Association for, Cancer Res, 18, 5134 Torres-Roca, 2015, Integration of a radiosensitivity molecular signature into the assessment of local recurrence risk in breast cancer, Int J Radiat Oncol Biol Phys, 93, 631, 10.1016/j.ijrobp.2015.06.021 Ahmed, 2015, Differences between colon cancer primaries and metastases using a molecular assay for tumor radiation sensitivity suggest implications for potential oligometastatic SBRT patient selection, Int J Radiat Oncol Biol Phys, 92, 837, 10.1016/j.ijrobp.2015.01.036 Ahmed, 2015, The radiosensitivity index predicts for overall survival in glioblastoma, Oncotarget, 6, 34414, 10.18632/oncotarget.5437 Strom, 2015, Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer, Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 117, 159, 10.1016/j.radonc.2015.07.018 Mohammadi, 2020, Using the radiosensitivity index (RSI) to predict pelvic failure in endometrial cancer treated with adjuvant radiation therapy, Int J Radiat Oncol Biol Phys, 106, 496, 10.1016/j.ijrobp.2019.11.013 Dewan, 2009, Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody, Clin Cancer Res, 15, 5379, 10.1158/1078-0432.CCR-09-0265 Vanpouille-Box, 2018, Toward precision radiotherapy for use with immune checkpoint blockers, Clin Cancer Res, 24, 259, 10.1158/1078-0432.CCR-16-0037 Krombach, 2019, Priming anti-tumor immunity by radiotherapy: dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells, Oncoimmunology, 8, e1523097, 10.1080/2162402X.2018.1523097 Gupta, 2012, Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation, J Immunol, 189, 558, 10.4049/jimmunol.1200563 Shiao, 2010, The tumor-immune microenvironment and response to radiation therapy, J Mammary Gland Biol Neoplasia, 15, 411, 10.1007/s10911-010-9194-9 Yoshimura, 2013, Microenvironment and radiation therapy, Biomed Res Int, 2013, 10.1155/2013/685308 Thibodeau, 2015, Gene Expression Characterization of HPV Positive Head and Neck Cancer to Predict Response to Chemoradiation, Head Neck Pathol, 9, 345, 10.1007/s12105-014-0597-6 Wu, 2021, clusterProfiler 4.0: A universal enrichment tool for interpreting omics data, Innovation (camb), 2 Sun, 2021, Identification and validation of 17-lncRNA related to regulatory T cell heterogeneity as a prognostic signature for head and neck squamous cell carcinoma, Front Immunol, 12, 10.3389/fimmu.2021.782216 Schito, 2020, Metronomic chemotherapy offsets HIFα induction upon maximum-tolerated dose in metastatic cancers, EMBO Mol Med, 12, e11416, 10.15252/emmm.201911416 Guarnieri, 1980, Enhanced contractile response and protein kinase activation to threshold levels of beta-adrenergic stimulation in hyperthyroid rat heart, J Clin Invest, 65, 861, 10.1172/JCI109738 Mayakonda, 2018, Maftools: efficient and comprehensive analysis of somatic variants in cancer, Genome Res, 28, 1747, 10.1101/gr.239244.118 Brix, 2021, Analysis of clonogenic growth in vitro, Nat Protoc, 16, 4963, 10.1038/s41596-021-00615-0 Wang, 2011, Organ-sparing radiation therapy for head and neck cancer, Nature reviews Clin Oncol, 8, 639, 10.1038/nrclinonc.2011.106 Aupérin, 2020, Epidemiology of head and neck cancers: an update, Curr Opin Oncol, 32, 178, 10.1097/CCO.0000000000000629 Simard, 2014, International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site, Oral Oncol, 50, 387, 10.1016/j.oraloncology.2014.01.016 Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 Marabelle, 2020, Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study, The Lancet Oncology, 21, 1353, 10.1016/S1470-2045(20)30445-9 Ota, 2021, High tumor mutational burden predicts worse prognosis for cervical cancer treated with radiotherapy, Jpn J Radiol Yuan, 2020, The prognostic value of tumor mutational burden and immune cell infiltration in esophageal cancer patients with or without radiotherapy, Aging, 12, 4603, 10.18632/aging.102917 Chung, 2004, Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression, Cancer Cell, 5, 489, 10.1016/S1535-6108(04)00112-6 Zuo, 2020, LncRNA TTN-AS1/miR-134-5p/PAK3 axis regulates the radiosensitivity of human large intestine cancer cells through the P21 pathway and AKT/GSK-3β/β-catenin pathway, Cell Biol Int, 44, 2284, 10.1002/cbin.11436 Lin, 2018, FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival, Carcinogenesis, 39, 1320 Hutchinson, 2020, Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer, Oncogene, 39, 3638, 10.1038/s41388-020-1250-3 Wang, 2017, Radiation resistance in KRAS-mutated lung cancer is enabled by stem-like properties mediated by an osteopontin-EGFR pathway, Cancer Res, 77, 2018, 10.1158/0008-5472.CAN-16-0808 Begg, 2011, Strategies to improve radiotherapy with targeted drugs, Nat Rev Cancer, 11, 239, 10.1038/nrc3007 Yang, 2013, Small ubiquitin-like modifier 1–3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival, Cancer Sci, 104, 70, 10.1111/cas.12047 Tu, 2022, Lipid metabolism regulation based on nanotechnology for enhancement of tumor immunity, Front Pharmacol, 13, 10.3389/fphar.2022.840440 England-Mason, 2022, Prenatal exposure to phthalates and peripheral blood and buccal epithelial DNA methylation in infants: an epigenome-wide association study, Environ Int, 163, 10.1016/j.envint.2022.107183 Song, 2021, Sialidase of glaesserella parasuis augments inflammatory response via desialylation and abrogation of negative regulation of siglec-5, Infect Immun, 89, 10.1128/IAI.00696-20 Kazim, 2020, The transcription elongation factor TCEA3 induces apoptosis in rhabdomyosarcoma, Cell Death Dis, 11, 67, 10.1038/s41419-020-2258-x Cha, 2013, TCEA3 binds to TGF-beta receptor I and induces Smad-independent, JNK-dependent apoptosis in ovarian cancer cells, Cell Signal, 25, 1245, 10.1016/j.cellsig.2013.01.016 Blom, 2015, LAPTM4B facilitates late endosomal ceramide export to control cell death pathways, Nat Chem Biol, 11, 799, 10.1038/nchembio.1889 Li, 2012, The amplified cancer gene LAPTM4B promotes tumor growth and tolerance to stress through the induction of autophagy, Autophagy, 8, 273, 10.4161/auto.8.2.18941 Li, 2011, Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells, Cancer Res, 71, 7481, 10.1158/0008-5472.CAN-11-0940 Gupta, 2021, Lysosomal retargeting of Myoferlin mitigates membrane stress to enable pancreatic cancer growth, Nat Cell Biol, 23, 232, 10.1038/s41556-021-00644-7 Zhang, 2018, A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer, Nat Commun, 9, 3726, 10.1038/s41467-018-06179-0 He, 2021, A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression, Clin Transl Med, 11, e289, 10.1002/ctm2.289 Blomme, 2017, Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer, Oncogene, 36, 2116, 10.1038/onc.2016.369 Harada, 2021, Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance, Gastric Cancer, 24, 1264, 10.1007/s10120-021-01206-4 Meng, 2016, LAPTM4B: an oncogene in various solid tumors and its functions, Oncogene, 35, 6359, 10.1038/onc.2016.189 Li, 2010, Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer, Nat Med, 16, 214, 10.1038/nm.2090 Kiyono, 2009, Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells, Cancer Res, 69, 8844, 10.1158/0008-5472.CAN-08-4401 Byun, 2017, The Significance of VSIG4 expression in ovarian cancer, Int J Gynecol Cancer, 27, 872, 10.1097/IGC.0000000000000979 Vogt, 2006, VSIG4, a B7 family-related protein, is a negative regulator of T cell activation, J Clin Invest, 116, 2817, 10.1172/JCI25673 Jung, 2012, Protective role of V-set and immunoglobulin domain-containing 4 expressed on kupffer cells during immune-mediated liver injury by inducing tolerance of liver T- and natural killer T-cells, Hepatology, 56, 1838, 10.1002/hep.25906 Liao, 2014, VSIG4 expression on macrophages facilitates lung cancer development, Lab Invest, 94, 706, 10.1038/labinvest.2014.73 Kim, 2021, Expression of the immune checkpoint molecule V-set immunoglobulin domain-containing 4 is associated with poor prognosis in patients with advanced gastric cancer, Gastric Cancer, 24, 327, 10.1007/s10120-020-01120-1 Xu, 2015, VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients, Am J Transl Res, 7, 1172 Liu, 2021, Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma, Cancer Cell Int, 21, 101, 10.1186/s12935-021-01795-1 Yang, 2020, TPPP3 associated with prognosis and immune infiltrates in head and neck squamous carcinoma, Biomed Res Int, 2020, 3962146, 10.1155/2020/3962146 Li, 2019, Isoforms S and L of MRPL33 from alternative splicing have isoformspecific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway, Int J Oncol, 54, 1591 Keek, 2021, A prospectively validated prognostic model for patients with locally advanced squamous cell carcinoma of the head and neck based on radiomics of computed tomography images, Cancers (basel), 13, 10.3390/cancers13133271